Alexza Pharmaceuticals (ALXA) Tops Q2 EPS by 4c
More News related to ALXA
- Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
- Alexza Pharmaceuticals (ALXA) Reports Large Q3 Loss
- Alexza Reports 2009 Third Quarter Financial Results and Updates AZ-004 (Staccato(R) Loxapine) NDA Status
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
More News related to Earnings
- Copart (CPRT) Reports Q1 EPS of $0.42, Beats by 1c
- PDL BioPharma (PDLI) Reports Q4 Revenues
- Shanda Games (GAME) Reports Q3 Adj-EPS of $0.24
- American Technology (ATCO) Posts Q3 Loss of 3c, Misses Views; Revs Higher Y/Y
- American Technology (ATCO) Reports '09 Financials
Alexza Pharmaceuticals (Nasdaq: ALXA) reports a Q2 loss of $0.43, 4 cents better than the analyst estimate of ($0.47). No revenues were reported for the quarter.
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
